Semax
NootropicHover to zoom

Qualified Research Reference

Semax

Semax is documented for controlled research models and literature-based evaluation only.

Lab TestedThird-party · Janoshik Analytical · ISO 17025View COA / Lab Report →
Formulation Strength
5mgper vial
Member Pricing
Regular
$64.99
Elite Member10%
$58.49
1
Research Description

Semax is a synthetic heptapeptide analog of ACTH(4-10) supplied as a lyophilized research reagent. Manufactured to a high-purity analytical standard.

Investigated in BDNF expression, dopaminergic signaling, neuroprotection modeling, and cognitive-pathway research.

Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.

Research Profile

Semax: investigational profile.

Research Mechanism

A synthetic heptapeptide analog of ACTH(4-10) investigated for BDNF and NGF expression, dopaminergic tone, and neuroprotection in cortical models. Frequently studied alongside Selank as a complementary neuropeptide.

Investigational Profile

Developed at the Institute of Molecular Genetics in Moscow during the 1980s and 1990s, with a continuous Russian-language and translated neuroscience literature since.

Research Study Window

Cognitive-marker and neurotrophin endpoints are typically evaluated across ten- to fourteen-day pulsed laboratory protocols.

Pairs With

Selank

Pairs With

Selank

Formulation

Ingredients, disclosed.

Every compound and formulation strength documented without proprietary blends.

Compound
Dose
Research Context
Semax
Per protocol
Synthetic heptapeptide analogue of ACTH(4-10) developed for neuropeptide and neurotrophin research.
Characteristics

Composition, documented.

Molecular Formula
C37H51N9O10S
Molar Mass
813.93 g/mol
Amino Acid Sequence
H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
Synonyms
ACTH(4-7) analog, Russian nootropic heptapeptide
Solubility
Water-soluble
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder
FAQ

Questions, answered.